Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Tokyo - Delayed Quote JPY

Fukuda Denshi Co., Ltd. (6960.T)

Compare
6,080.00
-60.00
(-0.98%)
At close: April 4 at 3:30:00 PM GMT+9
Loading Chart for 6960.T
  • Previous Close 6,140.00
  • Open 6,050.00
  • Bid 6,060.00 x --
  • Ask 6,100.00 x --
  • Day's Range 6,020.00 - 6,120.00
  • 52 Week Range 5,770.00 - 7,870.00
  • Volume 20,000
  • Avg. Volume 17,534
  • Market Cap (intraday) 175.278B
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) 10.12
  • EPS (TTM) 600.70
  • Earnings Date May 13, 2025 - May 19, 2025
  • Forward Dividend & Yield 120.00 (1.97%)
  • Ex-Dividend Date Mar 28, 2025
  • 1y Target Est 6,950.00

Fukuda Denshi Co., Ltd. engages in the manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph and stress test products; patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems, such as data management software. Fukuda Denshi Co., Ltd. was founded in 1939 and is based in Tokyo, Japan.

fukuda.com

3,443

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 6960.T

View More

Performance Overview: 6960.T

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

6960.T
15.60%
Nikkei 225 (^N225)
15.33%

1-Year Return

6960.T
2.75%
Nikkei 225 (^N225)
15.07%

3-Year Return

6960.T
62.12%
Nikkei 225 (^N225)
21.79%

5-Year Return

6960.T
71.53%
Nikkei 225 (^N225)
89.56%

Compare To: 6960.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6960.T

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    175.28B

  • Enterprise Value

    111.10B

  • Trailing P/E

    10.12

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.25

  • Price/Book (mrq)

    1.00

  • Enterprise Value/Revenue

    0.79

  • Enterprise Value/EBITDA

    4.37

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.41%

  • Return on Assets (ttm)

    7.32%

  • Return on Equity (ttm)

    10.02%

  • Revenue (ttm)

    140.46B

  • Net Income Avi to Common (ttm)

    17.43B

  • Diluted EPS (ttm)

    600.70

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    65.98B

  • Total Debt/Equity (mrq)

    1.03%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 6960.T

View More

Company Insights: 6960.T

Research Reports: 6960.T

View More

People Also Watch